Individual Patient Expanded Access, sometimes referred to as "compassionate use," is a regulatory pathway that allows patients with serious or life-threatening conditions, such as cancer, to access investigational treatments outside of clinical trials. This is often considered when no comparable or satisfactory alternative therapy options are available, and the patient is not eligible for any ongoing clinical trials.
